340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Report: Patient Groups Mum on High Drug Costs


 

Print Article

February 23, 2017—Big Pharma pours so much money into patient advocacy groups that the dough renders them mute on the drug price issue, according to a trenchant piece in USAToday.

“The National Patient Advocate Foundation receives 60 percent of its $2 million budget from the pharmaceutical industry, while the Colon Cancer Alliance gets 15 percent of its $1.2 million budget,” says the publication. “Several other groups get up to 20 percent of their revenue from drug companies.”

And surprise, surprise: NPAF and CCA have been harsh critics of the 340B drug discount program.

We’ve highlighted these conflicts of interest before but the alarm can’t be sounded often enough. While there are natural reasons drug companies and disease advocacy groups work closely, the enormous money spent gives the industry a convenient check on organized patient criticism on nearly any issue.

That investment has paid off handsomely in the drug pricing fight now gripping Washington. Currently, insurance companies and health providers are facing off against Big Pharma with hardly a patient in sight. Some patient groups put drug costs far down the list of priorities. “NPAF’s 2015 data on calls from about 14,000 cancer patients shows transportation was the top concern, followed by hospital and doctor co-pays, rent and mortgages and then prescription co-pays,” says the USAToday story.

Such is the power of the drug industry, even as it stumbles consistently in its effort to counter public ire over astronomical prices.

For a more realistic view of the situation, a new report in the Journal Cancer indicates some patients are cutting corners on their own treatment to avoid high drug bills.

340B helps needy patients avoid these impossible situations. Each day, thousands of Americans receive free or discounted medications and clinical services thanks to the program.

Recent Articles

  • HRSA Still Plans to Start Enforcing New 340B Regulation on April 1
  • Big Pharma Plays the Blame Game on Drug Prices
  • Report: Patient Groups Mum on High Drug Costs

Follow us on Twitter

340B HealthFollow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340B Health
340BHealth340B Health@340BHealth·
10h

.@BosBizJournal reports that @HRSAGov sent @Merck a letter stating the company’s restrictions on discounts to safety-net hospitals are in violation of federal law. via @cassiemcgrath_: https://bit.ly/3yJgXqj #340B #Protect340B #Mapoli $MRK

Reply on Twitter 1527405393776889862Retweet on Twitter 1527405393776889862Like on Twitter 1527405393776889862Twitter 1527405393776889862
340BHealth340B Health@340BHealth·
13h

Patients shouldn’t have to jump over hurdles to access #healthcare services and discounts on vital medications. But that is what 16 #pharma companies are forcing them to do. Learn more: http://www.stop340bcuts.org #340B #Protect340B

Reply on Twitter 1527371531575525376Retweet on Twitter 1527371531575525376Like on Twitter 1527371531575525376Twitter 1527371531575525376
340BHealth340B Health@340BHealth·
17h

#340B savings fund programs at safety-net hospitals to help patients manage #asthma. These hospitals treat more low-income patients with the disease than non-340B hospitals. Learn more: https://bit.ly/3ll3tt2 #Protect340B #AsthmaMonth

Reply on Twitter 1527307653252149249Retweet on Twitter 15273076532521492491Like on Twitter 15273076532521492492Twitter 1527307653252149249
Load More...

RSS 340B Informed

  • With 340B Pricing Restrictions, Hospitals Are Facing Double the Trouble
  • Faces of 340B: Community Pharmacy Partnerships Aid in the Cancer Care Cause
  • 340B Community Pharmacy Legal Battle Moves to Next Stage

Copyright © 2022 · 340B Health